Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Income from Continuing Operations (2020 - 2025)

Bio Essence (BIOE) has 6 years of Income from Continuing Operations data on record, last reported at 12998.0 in Q3 2025.

  • For Q3 2025, Income from Continuing Operations rose 101.08% year-over-year to 12998.0; the TTM value through Sep 2025 reached 160453.0, up 89.52%, while the annual FY2024 figure was 1565721.0, 286.98% down from the prior year.
  • Income from Continuing Operations reached 12998.0 in Q3 2025 per BIOE's latest filing, down from 59864.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 68664.0 in Q4 2022 and bottomed at 1199493.0 in Q3 2024.
  • Average Income from Continuing Operations over 5 years is 172434.79, with a median of 163538.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: surged 175.76% in 2022, then plummeted 1041.83% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 90634.0 in 2021, then soared by 175.76% to 68664.0 in 2022, then tumbled by 90.64% to 6425.0 in 2023, then plummeted by 529.0% to 27563.0 in 2024, then surged by 147.16% to 12998.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 12998.0 in Q3 2025, 59864.0 in Q2 2025, and 205752.0 in Q1 2025.